Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01MPE
|
|||
| Former ID |
DIB003829
|
|||
| Drug Name |
S-2150
|
|||
| Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C3H6N4
|
|||
| Canonical SMILES |
CC1=NC(=NN1)N
|
|||
| InChI |
1S/C3H6N4/c1-2-5-3(4)7-6-2/h1H3,(H3,4,5,6,7)
|
|||
| InChIKey |
FJRZOOICEHBAED-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 4923-01-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calcium channel unspecific (CaC) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pharmacodynamics of S-2150, a simultaneous calcium-blocking and alpha1-inhibiting antihypertensive drug, in rats. J Pharm Pharmacol. 2000 Mar;52(3):273-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.